Comparison of the efficacy and safety of transarterial chemoembolization with and without Apatinib for the treatment of BCLC stage C hepatocellular carcinoma
Số trang: 8
Loại file: pdf
Dung lượng: 802.40 KB
Lượt xem: 4
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
Hepatocellular carcinoma (HCC) is a common cancer worldwide, with a poor prognosis. Most patients are diagnosed at advanced stages and are only eligible for palliative therapy.
Nội dung trích xuất từ tài liệu:
Comparison of the efficacy and safety of transarterial chemoembolization with and without Apatinib for the treatment of BCLC stage C hepatocellular carcinoma
Nội dung trích xuất từ tài liệu:
Comparison of the efficacy and safety of transarterial chemoembolization with and without Apatinib for the treatment of BCLC stage C hepatocellular carcinoma
Tìm kiếm theo từ khóa liên quan:
BMC Cancer Hepatocellular carcinoma Cancer worldwide Palliative therapy Tumor-response rateGợi ý tài liệu liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 171 0 0 -
6 trang 166 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 141 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 112 0 0 -
12 trang 91 0 0
-
19 trang 74 0 0
-
17 trang 62 0 0
-
9 trang 39 0 0
-
11 trang 37 0 0
-
12 trang 36 0 0